
The HbA1c rapid test enables the quantitative determination of glycated hemoglobin (HbA1c) from capillary or venous whole blood. It is used to monitor long-term blood glucose control in patients with diabetes mellitus and supports the early detection of at-risk patients. The test is precise, fast, and easy to perform – ideal for point-of-care use in medical practices, clinics, or pharmacies.
Thanks to state-of-the-art technology, the test delivers lab-comparable results in just 3 minutes using only a small amount of blood . The system is compact, portable, and user-friendly – perfect for effective on-site patient care.
Areas of application:
-
Long-term blood glucose monitoring in type 1 and type 2 diabetes
-
Early detection of diabetes and prediabetes
-
Screening of high-risk patients with metabolic syndrome
-
Use in general practitioner practices , internal medicine practices , pharmacies , clinics , and healthcare centers
Advantages at a glance:
-
Fast test results in approximately 3 minutes
-
High measurement accuracy , comparable to central laboratories
-
Only a few microliters of blood are needed.
-
Easy to use – no special laboratory training required
-
Compact and portable – ideal for on-site use
-
Helpful in therapy decisions and monitoring progress
Further information:
-
Especially suitable for point-of-care diagnostics
-
Reduces waiting times and enables fast clinical decisions
-
Supports regular monitoring within the framework of structured treatment programs (DMP)
-
Compatible with various analyzers (e.g., Afinion™ 2) depending on the system.
Delivery information: 15 tests
PZN: " "
WEEE number:
Assistive device number:
Manufacturer:
ABBOTT MEDICAL GMBH
Schanzenfeldstraße 2
D–35578 Wetzlar
Deutschland
Tel: +49 (0) 6441 870 75 0
Email: WETCustomerService@av.abbott.com
VAT ID number: